Benchmarking DFT Accuracy in Predicting O 1s Binding Energies on Metals حسب Elizabeth E. Happel (22391811)

الموضوعات:

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( حسب Farrokh Habibzadeh (12256529)

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( حسب Farrokh Habibzadeh (12256529)

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( حسب Farrokh Habibzadeh (12256529)

Polylactic Acid/Polybutylene Adipate Terephthalate-Carbon Nanotube Nanobiocomposites with a Segregated Toughening Morphology Yielding Large Ductility for Biocompatible Materials حسب Utsab Ayan (18552401)

الموضوعات:

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

Linear regressions of consumer stable carbon and nitrogen isotope values and collection date. حسب Nathan D. McTigue (10706460)

الموضوعات:

Mathematical treatments applied to data to correct stable isotope values for lipid content. حسب Nathan D. McTigue (10706460)

الموضوعات:

Typical cases of normal esophageal diameter. حسب Hiromichi Hara (768931)

The number of expected vaccinations decreases with the expected vaccination time, whereas the peak of infections increases. حسب Simon K. Schnyder (16632244)

Costs and Benefits of Popular <i>P</i>‑Value Correction Methods in Three Models of Quantitative Omic Experiments حسب Steven R. Shuken (14500192)

"…The tremendous false discovery rate (FDR) benefit of correction was confirmed in a range of different contexts. No correction method can guarantee a low FDP in a single experiment, but the probability of a high FDP is small when a high number and proportion of corrected <i>p</i>-values are significant. …"

Proportion of genotype calls with both alleles correct (2), one allele incorrect (1) and two alleles incorrect (0) at different sequencing coverages. حسب Harrison J. Lamb (11722247)

Survival probability of cercariae in 0.38 ppt, 1.9 ppt, 3.8 ppt, and 5.7 ppt salinity treatments over a 24-hour period. حسب Ao Yu (1348512)

Same as Fig 2A but for DENV 3, without fine resolution added. حسب Shaowei Sang (520418)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. حسب Elizabeth S. Munroe (21568166)

Species occurrence along the NO₃¯ gradient (sorted by decreasing 25th percentile values). حسب Willem Kaijser (12872371)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. حسب Elizabeth S. Munroe (21568166)